Compare Adaptive Biotechnologies Corp (ADPT) vs Home Depot Inc (HD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Home Depot Inc — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Home Depot Inc trades at $336.05 (market cap $344.21B). The key difference: Home Depot Inc is far larger — about 103.4× Adaptive Biotechnologies Corp's market cap, and Home Depot Inc pays a 2.7% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | HD | |
|---|---|---|
Market Cap | $3.33B | $344.21B |
Sector | Health | Consumer Cyclical |
52-Week High | $22.37 | $423.42 |
52-Week Low | $10.24 | $297.51 |
Enterprise Value | $3.19B | $405.77B |
Dividend Yield | — | 2.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Home Depot (HD) trades at $345.21, down 1.55% on the day, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported $159.51B in 2025 revenue with strong profitability (8.41% net margin) and maintains a solid dividend. Recent earnings show beats in Q4 2025 and Q1 2026, though Q3 2025 missed expectations. Analyst consensus remains bullish with a $370.59 price target, representing 7.4% upside potential from current levels.
HD presents a compelling investment case with strong fundamentals and analyst support, though faces headwinds from weakening big-ticket demand and margin pressure. The stock's current valuation (P/E 24.52) appears reasonable given the company's market leadership and Pro business growth potential. Key risks include housing market sensitivity and rising interest rates impacting consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
